BAX
42
-5
LYB
13
-7
D
43
-2
ZTS
10
-6
AVGO
26
-2
DG
68
13
HPE
45
7
GLW
65
4
HUM
33
-3
IVZ
68
15
EW
60
7
CI
42
-3
APH
58
2
EXR
22
-17
INTC
44
-8
WMB
55
4
TRIP
58
-2
WY
37
-2
TDC
80
-3
AAL
50
-4
BAX
42
-5
LYB
13
-7
D
43
-2
ZTS
10
-6
AVGO
26
-2
DG
68
13
HPE
45
7
GLW
65
4
HUM
33
-3
IVZ
68
15
EW
60
7
CI
42
-3
APH
58
2
EXR
22
-17
INTC
44
-8
WMB
55
4
TRIP
58
-2
WY
37
-2
TDC
80
-3
AAL
50
-4
Financhill
Back

Amneal Pharmaceuticals, Inc. 10K Form

Buy
75

AMRX
Amneal Pharmaceuticals, Inc.

Last Price:
$12.01
Seasonality Move:
-1.34%

7 Day Trial

ALL ACCESS PASS

$ 7

Key Filings

10K form not available

Receive AMRX News And Ratings

See the #1 stock for the next 7 days that we like better than AMRX

AMRX Financial Statistics

Sales & Book Value

Annual Sales: $2.8B
Cash Flow: $96M
Price / Cash Flow: 16.17
Annual Sales: $-0.35
Price / Book: 5.62

Profitability

EPS (TTM): 0.01410
Net Income (TTM): $57.6M
Gross Margin: $1B
Return on Equity: -587.3%
Return on Assets: 1.66%

Amneal Pharmaceuticals, Inc. Earnings Forecast

Key Amneal Pharmaceuticals, Inc. Financial Ratios

  • The Gross Profit Margin over the past 9 years for AMRX is 36.52%.
  • The Selling, General & Administrative Expenses for AMRX have been equal to 17.05% of Gross Profit Margin.
  • The Research & Development expenses have been 6.83% of Revenue.
  • The Net Earning history of AMRX is -2.64% of Total Revenues.
  • Per Share Earnings over the last 9 years have been positive in 3 years.

Amneal Pharmaceuticals, Inc. Stock Price Chart

Industry, Sector and Symbol

Stock Exchange: NASDAQ
Industry: Pharmaceuticals
Sector: Health Care
Current Symbol: AMRX
CUSIP: 03168L
Website: amneal.com

Debt

Debt-to-Equity Ratio: -24.54
Current Ratio: 2.13
Quick Ratio: 1.31

Price-to-Earnings

Trailing P/E Ratio: 0
Forward P/E Ratio: 12.67

AMRX Technical Analysis vs Fundamental Analysis

Buy
75
Amneal Pharmaceuticals, Inc. (AMRX) is a Buy

Is Amneal Pharmaceuticals, Inc. a Buy or a Sell?